Literature DB >> 20236061

Virtual screening in drug design and development.

Sérgio F Sousa1, Nuno M F S A Cerqueira, Pedro A Fernandes, Maria João Ramos.   

Abstract

Virtual screening (VS) is presently a key component in the process of drug design and development. VS is normally regarded as the selection of likely drug candidates from large libraries of chemical structures by using computational methodologies. However, the generic definition of VS is significantly wider and may encompass many different methods. This review tries to present a comprehensive overview of the virtual screening process and of its importance in the present drug discovery and development paradigm. Following a focused contextualization on the subject, an introduction to the general types of virtual screening methodologies is presented. The main stages of a virtual screening campaign, including its strengths and limitations, are the subject of particular attention in this review. This analysis is complemented with a careful selection of VS success stories. Finally, a reflection on the future challenges of this promising methodology is drawn.

Mesh:

Substances:

Year:  2010        PMID: 20236061     DOI: 10.2174/138620710791293001

Source DB:  PubMed          Journal:  Comb Chem High Throughput Screen        ISSN: 1386-2073            Impact factor:   1.339


  17 in total

1.  Incorporating specificity into optimization: evaluation of SPA using CSAR 2014 and CASF 2013 benchmarks.

Authors:  Zhiqiang Yan; Jin Wang
Journal:  J Comput Aided Mol Des       Date:  2016-02-15       Impact factor: 3.686

Review 2.  Application of NMR and molecular docking in structure-based drug discovery.

Authors:  Jaime L Stark; Robert Powers
Journal:  Top Curr Chem       Date:  2012

3.  Octopus: a platform for the virtual high-throughput screening of a pool of compounds against a set of molecular targets.

Authors:  Eduardo Habib Bechelane Maia; Vinícius Alves Campos; Bianca Dos Reis Santos; Marina Santos Costa; Iann Gabriel Lima; Sandro J Greco; Rosy I M A Ribeiro; Felipe M Munayer; Alisson Marques da Silva; Alex Gutterres Taranto
Journal:  J Mol Model       Date:  2017-01-07       Impact factor: 1.810

4.  Investigating combinatorial approaches in virtual screening on human inducible 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFKFB3): a case study for small molecule kinases.

Authors:  Robert B Crochet; Michael C Cavalier; Minsuh Seo; Jeong Do Kim; Young-Sun Yim; Seung-Jong Park; Yong-Hwan Lee
Journal:  Anal Biochem       Date:  2011-07-02       Impact factor: 3.365

5.  New carvacrol and thymol derivatives as potential insecticides: synthesis, biological activity, computational studies and nanoencapsulation.

Authors:  Carolina M Natal; Maria José G Fernandes; Nuno F S Pinto; Renato B Pereira; Tatiana F Vieira; Ana Rita O Rodrigues; David M Pereira; Sérgio F Sousa; A Gil Fortes; Elisabete M S Castanheira; M Sameiro T Gonçalves
Journal:  RSC Adv       Date:  2021-10-21       Impact factor: 4.036

6.  Toward the design of alkynylimidazole fluorophores: computational and experimental characterization of spectroscopic features in solution and in poly(methyl methacrylate).

Authors:  Vincenzo Barone; Fabio Bellina; Malgorzata Biczysko; Julien Bloino; Teresa Fornaro; Camille Latouche; Marco Lessi; Giulia Marianetti; Pierpaolo Minei; Alessandro Panattoni; Andrea Pucci
Journal:  Phys Chem Chem Phys       Date:  2015-10-28       Impact factor: 3.676

7.  IVSPlat 1.0: an integrated virtual screening platform with a molecular graphical interface.

Authors:  Yin Xue Sun; Yan Xin Huang; Feng Li Li; Hong Yan Wang; Cong Fan; Yong Li Bao; Lu Guo Sun; Zhi Qiang Ma; Jun Kong; Yu Xin Li
Journal:  Chem Cent J       Date:  2012-01-05       Impact factor: 4.215

8.  Prospective Role of Peptide-Based Antiviral Therapy Against the Main Protease of SARS-CoV-2.

Authors:  Shafi Mahmud; Gobindo Kumar Paul; Suvro Biswas; Shamima Afrose; Mohasana Akter Mita; Md Robiul Hasan; Mst Sharmin Sultana Shimu; Alomgir Hossain; Maria Meha Promi; Fahmida Khan Ema; Kumarappan Chidambaram; Balakumar Chandrasekaran; Ali M Alqahtani; Talha Bin Emran; Md Abu Saleh
Journal:  Front Mol Biosci       Date:  2021-05-10

9.  Structural basis of type 2A von Willebrand disease investigated by molecular dynamics simulations and experiments.

Authors:  Gianluca Interlandi; Minhua Ling; An Yue Tu; Dominic W Chung; Wendy E Thomas
Journal:  PLoS One       Date:  2012-10-23       Impact factor: 3.240

Review 10.  Molecular Modeling Targeting Transmembrane Serine Protease 2 (TMPRSS2) as an Alternative Drug Target Against Coronaviruses.

Authors:  Igor José Dos Santos Nascimento; Edeildo Ferreira da Silva-Júnior; Thiago Mendonça de Aquino
Journal:  Curr Drug Targets       Date:  2022       Impact factor: 2.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.